Showing 1 - 10 of 11
Persistent link: https://www.econbiz.de/10011498384
Persistent link: https://www.econbiz.de/10012415120
Persistent link: https://www.econbiz.de/10012060106
Persistent link: https://www.econbiz.de/10012009103
Persistent link: https://www.econbiz.de/10011708133
This paper quantifies the relationship between market size and innovation in the pharmaceutical industry using improved, and newer, methods and data. We find positive significant elasticities of innovation to expected market size with a point estimate under our preferred specification of 0.23....
Persistent link: https://www.econbiz.de/10009369352
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is also characterized by extensive regulation of almost every activity, from product development through manufacturing and marketing, which we summarize. We next describe the...
Persistent link: https://www.econbiz.de/10014025576
This paper quantifies the relationship between market size and innovation in the pharmaceutical industry using improved, and newer, methods and data. We find positive significant elasticities of innovation to expected market size with a point estimate under our preferred specification of 0.23....
Persistent link: https://www.econbiz.de/10009002343
The goal of antitrust policy is to protect and promote a vigorous competitive process. Effective rivalry spurs firms to introduce new and innovative products, as they seek to capture profitable sales from their competitors and to protect their existing sales from future challengers. In this...
Persistent link: https://www.econbiz.de/10012479954
The goal of antitrust policy is to protect and promote a vigorous competitive process. Effective rivalry spurs firms to introduce new and innovative products, as they seek to capture profitable sales from their competitors and to protect their existing sales from future challengers. In this...
Persistent link: https://www.econbiz.de/10012867456